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Summary lar mechanism of the syndrome is based on a large
expansion of a CGG trinucleotide repeat (to ú200 re-
The fragile X syndrome is due to the new class of dy- peats) located in the 5-UTR of the FMR1 gene (fragile
namic mutations. It is associated with an expansion of X mental retardation gene 1) (Verkerk et al. 1991). This
a trinucleotide repeat (CGG) in exon 1 of the fragile X full mutation is associated with hypermethylation of
mental retardation gene 1 gene (FMR1). Here we pre- both the CGG repeat and an upstream CpG island, re-
sent a fragile X family with an unique female patient sulting in repression of expression of the FMR1 gene
who was rendered hemizygous for the FRAXA locus (Pieretti et al. 1991). The transition is strictly maternal,
due to a large deletion of one X chromosome. In addi- although some minor expansions and regressions of re-
tion, the other X had a microdeletion in FMR1. PCR peat number in the premutation range (50–200 repeats)
and sequence analysis revealed that the microdeletion have been observed in father-to-daughter transmissions
included all CGG repeats plus 97 bp of ﬂanking se- (Fisch et al. 1995; Va¨isa¨nen et al. 1996).
quences, leaving transcription start site and translation Transmission of premutations is associated with a risk
start site intact. Despite this total lack of CGG repeats for an increase in repeat size when transmitted by a
in the FMR1 gene, Western blot analysis showed expres- female, but occasionally a reduction in repeat number
sion of FMRP, and the patient’s phenotype was essen- is seen, from premutation to a smaller premutation
tially normal. X-inactivation studies of the androgen- (Rousseau et al. 1991; Mornet et al. 1996) and from
receptor (AR) locus and haplotype determination of mi- premutation to normal size allele (Vits et al. 1994;
crosatellite markers gave evidence that the deletion Brown et al. 1996; Mornet et al. 1996). Regression from
probably originated from regression of a fully mutated a full mutation to a premutated allele has also been
FMR1 gene. Although the minimal number of CGG described (Fu et al. 1991; Rousseau et al. 1991; Malzac
repeats hitherto reported in FRAXA is six, and at least et al. 1996).
four other genes associated with CGG repeats are Several deletions in FMR1 have been characterized;
known, suggesting an as yet unknown function of these some are large deletions removing all of the FMR1 gene
repeats, our study clearly demonstrates that the absence plus ﬂanking sequences (Gedeon et al. 1992; Tarleton
of CGG repeats does not abolish expression of the et al. 1993; Quan et al. 1995; Birot et al. 1996), and
FMR1 gene in lymphoblastoid cells. some are deletions of part of FMR1 (Wo¨rhle et al. 1992;
Gu et al. 1994; Meijer et al. 1994; Trottier et al. 1994;
Hart et al. 1995; Hirst et al. 1995; Quan et al. 1995),Introduction
all associated with the fragile X syndrome in males. In
The fragile X syndrome is the most frequent form of addition to these deletions, a few females have been
inherited mental retardation (Oostra et al. 1995). The found with large X-chromosome deletions at Xq27-28.
clinical symptoms include mental retardation ranging Two of these had both their FMR1 and iduronatesulfa-
from moderate to profound, macroorchidism, and mi- tase genes deleted, and they were both mentally retarded
nor dysmorphic facial features often combined with au- (Clarke et al. 1992; Schmidt et al. 1992).
tism-like behavior (Oostra et al. 1995). Besides this group of fragile X patients, whose pheno-
In the vast majority of fragile X patients, the molecu- type is due to deletions of all or part of FMR1, another
group of patients with deletions in FMR1 are known.
These patients have relatively small deletions, all located
in the 5-UTR surrounding the CGG repeat of FMR1,Received November 8, 1996; accepted for publication July 9, 1997.
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ers (II-1 and II-2) who were both healthy and had nor-
mal CGG repeat numbers.
JL was an 11-year-old (10 years 10 mo) girl when
investigated by us. She was the ﬁrst of two children born
to a fully mutated fragile X mother. The pregnancy was
uneventful, but delivery was complicated by intrauterine
and perinatal asphyxia. Her birth weight was 2,500 g,
and the Apgar score was low. Requiring respirator treat-
ment, she was transferred to a neonatal intensive care
unit. Discharged in good health at 6 wk of age, she was
followed as outpatient for 5 years with social problems
only and was readmitted to hospital 9 years old because
of suspicion of precocious puberty (thelarche since 7
years 6 mo). She was a normally developed girl in terms
of psychomotor skills, with height at the 50% percentile.
Her phenotype was essentially normal, without Turner
syndrome stigmata. A hearing loss had been diagnosed,
and she wore hearing aids. Sexual pubertal developmentFigure 1 Pedigree of family, showing normal males (open
squares), carrier females (circles with a dot), affected males (ﬁlled corresponded to Tanner stage 2–3 without menarche.
squares), and affected females (ﬁlled circles). JL is marked by an arrow. Ultrasound investigation showed the presence of normal
Males not investigated are shown by an open square marked ‘‘ND.’’ uterus and ovaries. Conventional cytogenetic analysis
Genotypes for DXS548, FRAXAC1, and FRAXAC2 are shown below
(Q-banding) revealed a terminal deletion of the X chro-symbols.
mosome, karyotype 46,X,del(X)(q24).
Southern Blot Analysis
and revealed expression of FMRP in 28% of his
Genomic DNA was isolated from blood leukocyteslymphoblasts, corresponding well with the percentage
with the standard salting-out method (Miller et al.of cells carrying the deletion (patient 1 in ﬁg. 3B; de
1988). Seven micrograms of DNA were digested to com-Graaff et al. 1996).
pletion with EcoRI and EagI. After gel electrophoresisIn this article, we present a female patient who was
on a 0.7% agarose gel, the DNA was transferred tofound to possess a large cytogenetically visible presum-
Hybond N/ blotting membrane. The membrane wasably terminal deletion on one X chromosome
prehybridized in 0.5 M NaPi pH 7.2, 7% SDS, 1 mM(46,X,del[X][q24]), eliminating the FRAXA locus, and
EDTA, and hybridized with 32P-labeled pPX6 probe ata microdeletion on the other X chromosome. The micro-
65C overnight. The pPX6 is a 600-bp PstI-XhoI frag-deletion was located in exon 1 of the FMR1 gene, re-
ment that detects the CpG island and the (CGG)n re-moving all of the CGG repeats and some ﬂanking se-
peats. pPX6 was labeled using the random-primedquences on both sides. Despite the total lack of CGG
DNA-labeling kit from Boehringer Mannheim. After hy-repeats, Western blot analysis showed expression of
bridization, ﬁlters were washed in 40 mM NaPi pH 7.2,FMRP comparable to normal controls. The data pre-
1% SDS and in 20 mM NaPi pH 7.2, 1% SDS and weresented show that the CGG repeats and the immediate
analyzed either using a phosphorimager from Pharmaciaﬂanking sequences located in the 5-UTR of FMR1 may
or by standard autoradiography.not be necessary for expression of the gene in lym-
phoblastoid cells, but further experiments are necessary PCR and Sequencing
to elucidate whether they have an additional function.
Ampliﬁcation was performed using 100 ng genomicFrom haplotype analysis and X-inactivation studies, we
DNA in the presence of 20 mM Tris-HCl (pH 8.8), 2presume that the deletion originated as a regression of
mM MgSO4, 10 mM KCl, 10 mM (NH4)2SO4, 0.1%a full mutation. This deletion is the largest known so far
Triton X-100, 100 mg/ml BSA, 10% DMSO, 0.1 mMin which protein expression also has been investigated.
dGTP, 0.2 mM dATP, dCTP, and dTTP each, 0.1 mM
7-deaza dGTP, 0.8 mM of each primer FMRG (sensePatients, Material, and Methods
primer) (5-AGTGCGACCTGTCACCGCCCTTC-3)
Clinical Case Report and FMR1B (antisense primer) (5-AGGGCGAAG-
ATGGGGCCTGC-3) and 1.25 units cloned pfu poly-Patient JL (subject III-1) was referred to us for
FRAXA analysis because of her fully mutated mother merase, in a total volume of 25 ml. The DNA was dena-
tured for 5 min at 98C, followed by 35 cycles of(II-4) and brother (III-2) (ﬁg. 1). The premutation carrier
was the grandmother (I-1). The mother had two broth- denaturing at 98C for 1 min and annealing and exten-
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sion at 65C for 3 min. The ampliﬁcation was ended by
a ﬁnal extension at 72C for 7 min.
DNA sequencing was performed on the PCR fragment
using the same primers, which were end labeled by T4
kinase with g-32P-ATP. The Thermo Sequenase cycle se-
quencing kit (Amersham Life Science) was used follow-
ing the manufacturer’s instructions.
Haplotype PCR Analysis
The polymorphic markers (DXS548, FRAXAC1, and
FRAXAC2) in the region surrounding the FMR1 gene
were determined. Primers for FRAXAC1 and
FRAXAC2 were those described by Richards et al.
(1991), and primers for DXS548 were described by
Verkerk et al. (1991). PCR of FRAXAC1 was performed
using 100 ng genomic DNA in the presence of 10 mM
Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 0.25
mM dATP, dCTP, dGTP, and dTTP each, 0.25 mM
primers (FRAXAC1F was radioactive end labeled by T4
kinase), and 0.5 units Taq polymerase. The DNA was
denatured for 5 min before the rest of the components
were added (hot start); then 10 cycles of denaturing at
Figure 2 Southern blot analysis using probe pPX6 hybridized94C for 1 min, annealing at 60C for 1.5 min, and
to EcoRI- and EagI-digested DNA as described in Patients, Material,
extension at 72C for 1.5 min was performed, followed and Methods. The position and length of the normal fragments are
by 25 cycles with the annealing temperature lowered to indicated on the left side of the ﬁgure (2.8 and 5.2 kb), and, in addition,
the position and size of the deleted fragment in JL (2.6 kb) are shown55C. The protocol was ended by a ﬁnal extension step
on the lower ﬁgure. The subjects are indicated above lanes. NM andat 72C for 7 min. PCR of FRAXAC2 and DXS548 were
NF represent a normal male and normal female, respectively.performed using 100 ng genomic DNA in the presence of
10 mM Tris-HCl pH 8.3, 50 mM KCl, 1.2 mM MgCl2,
0.2 mM dATP, dCTP, dGTP and dTTP each, 5% glyc-
ture was centrifuged at 1,200 rpm for 5 min, and theerol, 0.27 mM each primer (of which FRAXAC2F and
pellet was washed twice in cold PBS. The pellet wasDXS548-1 were radioactive end labeled) and 0.5 units
resuspended in 100 ml of PBS with 2% SDS, 1 mMTaq polymerase. A hot start was performed as described
EDTA, 0.5 mg/ml, AEBSF, 10 mg/ml aprotenin, and 10for FRAXAC1. The DNA was denatured at 93C each
mg/ml leupeptin. The sample was boiled for 5 min, putfor 8 min followed by 28 cycles of 45 s denaturing at
93C, annealing for 1 minute at 52C, and extension for on ice, and new inhibitors were added. Insoluble mate-
2 min at 72C. A ﬁnal extension step at 72C for 7 min rial was pelleted by centrifugation at 15,000 g for 10
ended the protocol. min.
Thirty micrograms of protein extract (measured byX-Inactivation Analysis
standard Lowry method) were run on a 8% SDS-PAGEFor studying the X inactivation in the AR locus, 2 mg
and were blotted onto Hybond ECL membrane. Theof genomic DNA was digested to completion with
membrane was blocked in 5% milk powder in PBSTHpaII, and in parallel 2 mg of genomic DNA was incu-
(PBS, 0.1% Tween 20) and incubated with a monoclonalbated in the same buffer without enzyme. One half mi-
anti-FMR1 antibody (1C3-1a) diluted in PBST 1:2,500croliter of digested/undigested DNA was used for a PCR
or a monoclonal anti–retinoblastoma (Rb) antibodyreaction in the presence of 10 mM Tris-HCL, 50 mM
(1F8) diluted 1:20. The enhanced chemiluminescenceKCl, 1.5 mM MgCl2, 0.25 mM each primer (La Spada
system (Amersham, Life Science) was used as detectionet al. 1991) (AR2 end labeled), and 0.5 units Taq poly-
system following the manufacturer’s instructions.merase. The DNA was initially denatured at 94C for 5
min, followed by 25 cycles of denaturing at 94C for 30
Resultss, annealing at 60C for 45 s, and extension at 72C for
45 s. The ampliﬁcation was ended by a ﬁnal extension DNA Analysis
at 72C for 5 min. We performed Southern blot analysis using the pPX6
Western Blot Analysis probe on genomic DNA double digested with EcoRI and
the methylation-sensitive enzyme EagI (ﬁg. 2). Patient JLCytoplasmic proteins were isolated from Epstein-Barr
virus–transformed lymphocytes. Ten milliliters of cul- showed hybridization to only one fragment, which was
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smaller than the expected 2.8-kb fragment and estimated
to have a size of 2.6 kb. No smear corresponding to a
repeat size in the fully mutated range appeared on the
Southern blot, not even after overexposure (authors’ un-
published data). This was conﬁrmed on Southern blot
analysis using DNA isolated from the lymphoblastoid
cell line used for Western blot analysis (data not shown).
The Southern blot analysis revealed that subject I-1 car-
ried a premutation, which had expanded to a full muta-
tion in II-4. Both II-1 and II-2 appeared as normal males,
whereas III-2 was a fully mutated male.
PCR using primers FMRG and FMR1B (see Patients,
Material, and Methods), which would give a band size
of 618 bp in an individual with 30 CGG repeats, gave a
fragment of Ç450 bp in JL (authors’ unpublished data),
indicating that a deletion was present. In order to deter-
mine the exact breakpoints of the deletion, the PCR
fragment was sequenced. This revealed that JL had no
CGG repeats and, furthermore, that between 63 and 67
bp immediately 5 of the repeat and between 30 and 34
bp directly 3 of the repeat were deleted, leaving both
transcription start site and translation start site intact
(ﬁg. 3).
Protein Expression Studies
Western blot analysis using protein extracts isolated
from lymphoblastoid cells and a monoclonal anti-FMR1
antibody showed several bands in the normal control,
ranging in size from Ç70 kDa to 85 kDa, corresponding
Figure 3 A, Sequence of the region surrounding the breakpointsto different alternatively spliced forms (ﬁg. 4A). JL
of the deletion found in JL. The shown sequence starts at nt 2626showed expression of the same bands in the same
and ends at 2820 (numbering according to Fu et al. [1996] EMBLamounts as the normal control, in contrast to a fragile
accession no. X61378). The CGGG sequence that could be the ﬁrst
X patient who did not show any expression of FMRP or the last four bases deleted is shown in bold. B, Schematic representa-
(ﬁg. 4A). Using the Rb protein as a control, it was seen tion of the deletion in exon 1 of the FMR1 gene of JL (not drawn to
scale). All CGG repeats were deleted, and, in addition, 63–67 bpthat slightly more cell extract was loaded for JL than
immediately 5 to the CGG repeat and 30–34 bp 3 of the repeatfor the controls (ﬁg. 4B).
were deleted. Some of the other known deletions in this area are shown
Investigation of X-Chromosome Segregation and X for comparison and reference: 1 (de Graaff et al. 1996), 2–5 (de
Graaff et al. 1995), 6 (Mannermaa et al. 1996), 7 (Hirst et al. 1995),Inactivation
and 8–9 (Mila` et al. 1996).As an attempt to differentiate between the paternally
and maternally inherited X chromosome in JL, we deter-
mined the haplotypes for DXS548, FRAXAC1, and
tion. The smallest number of CGG repeats found inFRAXAC2 of I-1, II-1, II-2, II-4, and JL (results shown
FMR1 in the normal population is six (Fu et al. 1991),in ﬁg. 1) (unfortunately, JL’s father was unavailable for
and four other folate-sensitive fragile sites associatedinvestigation). From this analysis, it was obvious that
with CGG or CCG repeats are known (FRAXE, FRAXF,grandmaternal haplotype 2 4 6/ was the one segregat-
FRA16A, and FRA11B) (Nancarrow et al. 1994; Parrishing with the mutation. This haplotype was found in JL.
et al. 1994; Jones et al. 1995; Gecz et al. 1996; Gu etInvestigation of the AR locus polymorphism showed
al. 1996), of which two (FRAXE and FRA11B) havethat JL had one allele in common with her mother and
been associated with a gene (FMR2 and CBL2) (Jones etone allele different. The paternal allele was exclusively
al. 1995; Gecz et al. 1996; Gu et al. 1996). Furthermore,inactivated, as evidenced after digestion with HpaII (au-
CGG repeats are also found in the 5-UTR of otherthors’ unpublished data).
genes such as the breakpoint cluster region gene (Riggins
Discussion et al. 1994), and the core-binding factor beta subunit
gene (Hajra et al. 1995). Several groups have tried toThe function of the CGG repeats is unknown, but
several observations suggest that they may have a func- identify proteins binding to the CGG repeats to elucidate
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mosaic patients again demonstrates the instability of the
region, and it can be speculated that these deletions orig-
inated from regression of the full mutation, but this has
not been documented in any of the former cases. Here
we present data showing that the deletion originated
as a deletion of a full mutation. Genotyping of three
microsatellite markers (DXS548, FRAXAC1, and
FRAXAC2) in the region surrounding the FMR1 gene
revealed that JL inherited the allele that originally car-
ried the full mutation. Furthermore, the inherited mater-
nal allele was active with totally nonrandom inactiva-
tion of the paternal allele, as evidenced by Southern blot
(no band corresponding to inactive X) and AR locus
analysis (paternal allele exclusively inactive). This is the
ﬁrst unequivocal demonstration that a deletion in the
5-UTR of the FMR1 gene arose from regression of a
full mutation.
The time and mechanism of the CGG expansion are
not fully understood. One hypothesis states that expan-Figure 4 Western blot analysis using proteins extracted from
sion is a mitotic event taking place postzygotically. Thislymphoblastoid cells. A, Western blot analysis using an anti-FMRP
is supported by the fact that somatic variation is seenantibody (1C3-1a). The amount of total protein extract loaded is
indicated above lanes. K1 and K2 are normal male controls, and Fra within an individual (Wo¨rhle et al. 1993). The other
(X) is a fully mutated fragile X male. B, Western blot analysis using hypothesis states that expansion takes place meiotically
an anti-Rb antibody (1F8), performed to conﬁrm the amount of loaded only during oogenesis, which is consistent with the ob-
protein extract. The conditions were the same as in ﬁgure 4A.
servation that expansion is never seen in offspring of
premutated males (so-called normal transmitting males).
Fully mutated males carry only a premutation in theirthe function of the CGG repeats (if any), but so far no
ﬁnal conclusions have been made (Richards et al. 1993; gametes (Reyniers et al. 1993), which has been taken as
evidence for a mitotic expansion; however, experimentsYano-Yanagisawa et al. 1995; Deissler et al. 1996).
In this article, we describe a unique female patient showing that testicular cells of a 13-wk full-mutation
fetus contain only fully mutated alleles and no premu-who lacks all CGG repeats in the FMR1 gene. On one
X chromosome she has a large cytogenetically visible tated alleles support the hypothesis that expansion takes
place during maternal germ-line development or verydeletion from q24 to qter, and on the other X chromo-
some she has a microdeletion that removes all the CGG early in embryogenesis (Malter et al. 1997). Perhaps the
repeats are unstable both in meiosis and mitosis, butrepeats in exon 1 of the FMR1 gene plus 97 bp of ﬂank-
ing sequences dispersed as 63–67 bp 5 to the CGG this is pure speculation. Since JL inherited an unaltered
maternal haplotype for markers surrounding FMR1, werepeat in addition to 30–34 bp 3 to the repeat. The
reason for the uncertainty for the exact breakpoints is can conclude that regression did not take place as part
of a meiotic crossover event in the CGG repeat. Thethe fact that a CGGG sequence is either the ﬁrst or the
last four bases deleted (see ﬁg. 3A). Western blot analysis deletion event probably took place relatively early, since
no mosaicism was detected in JL; however, it cannot bedemonstrated that FMRP expression was not blocked
in lymphoblastoid cells from JL. Since JL did not display ruled out that JL showed mosaicism in other tissues.
It is generally accepted that fragile X syndrome isany mosaicism (which is in contrast to the other patients
known to have deletions in this region), it can be con- caused by the absence of FMRP. The phenotype of JL
was essentially normal. The problems this patient hadcluded that the CGG repeats in the 5-UTR of the FMR1
gene are not necessary for expression of the gene. Fur- (hearing problems and some deﬁcits in perceptual spatial
skills) could be ascribed to the problems in connectionthermore, there are no regulatory elements located 63
bp 5 to the repeat and 30 bp 3 to the repeat. These to the delivery or be due to the large deletion on the
other X. From a review of published cases with Xqconclusions only apply to the cells studied, that is,
lymphoblastoid cells, and further studies are necessary deletions, it was concluded that the phenotypic effect of
Xq0 is highly variable, presumably because of variableto investigate whether the lack of repeats has functions
elsewhere. inactivation (Geerkens et al. 1994). Thus, an essentially
normal phenotype is compatible with the large deletion;The instability of the CGG repeats in the FMR1 gene
is a well-known phenomenon. The presence of both a furthermore, the del(X)(q24) chromosome in JL was
preferentially inactivated.full mutation and a deletion in the CGG region in the
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CCG ampliﬁcation has an FMR1 deletion. Nat Genet 1:In this article, we present results showing that the
341–344CGG repeats located in the 5-UTR of the FMR1 gene
Geerkens C, Just W, Vogel W (1994) Deletions of Xq andplus 63 bp immediately 5 to the repeat and 30 bp di-
growth deﬁcit: a review. Am J Med Genet 50:105–113rectly 3 to the repeat do not contain any regulatory
Gu Y, Lugenbeel KA, Vockley JG, Grody WW, Nelson DLelements necessary for expression of the FMR1 gene.
(1994) A de novo deletion in FMR1 in a patient with devel-
opmental delay. Hum Mol Genet 3:1705–1706
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